Compare Humana Inc (HUM) vs Las Vegas Sands Corp. (LVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Las Vegas Sands Corp. — how do they compare? Humana Inc trades at $445 (market cap $47.61B), while Las Vegas Sands Corp. trades at $36.3 (market cap $23.19B). The key difference: Humana Inc is far larger — about 2.1× Las Vegas Sands Corp.'s market cap, and Las Vegas Sands Corp. pays the higher dividend (3.35%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Las Vegas Sands Corp. for 72 Days on average.
| HUM | LVS | |
|---|---|---|
Market Cap | $47.61B | $23.19B |
Volume | 1,827,332 | 4,822,073 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $69.49 |
52-Week Low | $163.67 | $35.81 |
Typical Hold Time | 53 Days | 72 Days |
Enterprise Value | $54.97B | $35.08B |
Dividend Yield | 0.89% | 3.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
LVS trades at $36.10, down 0.58% on the day, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth from $13.02B in 2025 to projected $13.7B in 2026, with consistent profitability margins around 12.5%. Recent news highlights Sands China's community initiatives and environmental certifications, supporting long-term positioning in Macao's tourism market.
Wall Street maintains strong bullish sentiment with 59% buy ratings and a $59.78 price target representing 66% upside potential. Key risks include high debt levels (73.15% debt-to-asset ratio) and Macao regulatory exposure. The current valuation at 13.88 P/E appears attractive relative to growth prospects, though technical indicators suggest near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →
